These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 12150888)
1. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Jamieson AM; Diefenbach A; McMahon CW; Xiong N; Carlyle JR; Raulet DH Immunity; 2002 Jul; 17(1):19-29. PubMed ID: 12150888 [TBL] [Abstract][Full Text] [Related]
2. Costimulation of multiple NK cell activation receptors by NKG2D. Ho EL; Carayannopoulos LN; Poursine-Laurent J; Kinder J; Plougastel B; Smith HR; Yokoyama WM J Immunol; 2002 Oct; 169(7):3667-75. PubMed ID: 12244159 [TBL] [Abstract][Full Text] [Related]
3. Activation of V gamma 9V delta 2 T cells by NKG2D. Rincon-Orozco B; Kunzmann V; Wrobel P; Kabelitz D; Steinle A; Herrmann T J Immunol; 2005 Aug; 175(4):2144-51. PubMed ID: 16081780 [TBL] [Abstract][Full Text] [Related]
4. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. Wiemann K; Mittrücker HW; Feger U; Welte SA; Yokoyama WM; Spies T; Rammensee HG; Steinle A J Immunol; 2005 Jul; 175(2):720-9. PubMed ID: 16002667 [TBL] [Abstract][Full Text] [Related]
5. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells. Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119 [TBL] [Abstract][Full Text] [Related]
6. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. Rabinovich BA; Li J; Shannon J; Hurren R; Chalupny J; Cosman D; Miller RG J Immunol; 2003 Apr; 170(7):3572-6. PubMed ID: 12646619 [TBL] [Abstract][Full Text] [Related]
7. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Diefenbach A; Jamieson AM; Liu SD; Shastri N; Raulet DH Nat Immunol; 2000 Aug; 1(2):119-26. PubMed ID: 11248803 [TBL] [Abstract][Full Text] [Related]
9. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Pende D; Cantoni C; Rivera P; Vitale M; Castriconi R; Marcenaro S; Nanni M; Biassoni R; Bottino C; Moretta A; Moretta L Eur J Immunol; 2001 Apr; 31(4):1076-86. PubMed ID: 11298332 [TBL] [Abstract][Full Text] [Related]
10. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Diefenbach A; Hsia JK; Hsiung MY; Raulet DH Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935 [TBL] [Abstract][Full Text] [Related]
11. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Bauer S; Groh V; Wu J; Steinle A; Phillips JH; Lanier LL; Spies T Science; 1999 Jul; 285(5428):727-9. PubMed ID: 10426993 [TBL] [Abstract][Full Text] [Related]
13. A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor. Zhou H; Luo Y; Kaplan CD; Krüger JA; Lee SH; Xiang R; Reisfeld RA Blood; 2006 Apr; 107(8):3251-7. PubMed ID: 16368879 [TBL] [Abstract][Full Text] [Related]
14. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells. Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177 [TBL] [Abstract][Full Text] [Related]
15. IL-2-activated CD8+CD44high cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells. Dhanji S; Teh HS J Immunol; 2003 Oct; 171(7):3442-50. PubMed ID: 14500639 [TBL] [Abstract][Full Text] [Related]
16. NKG2D ligation without T cell receptor engagement triggers both cytotoxicity and cytokine production in dendritic epidermal T cells. Nitahara A; Shimura H; Ito A; Tomiyama K; Ito M; Kawai K J Invest Dermatol; 2006 May; 126(5):1052-8. PubMed ID: 16484989 [TBL] [Abstract][Full Text] [Related]